P2.02-065 RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors
- Resource Type
- Abstract
- Authors
- Tessari, A.; Palmieri, D.; Pawlikowski, M.; Parbhoo, K.; Foray, C.; Fassan, M.; La Perle, K.; Rulli, E.; Fabbri, A.; Ganzinelli, M.; Embrione, V.; Broggini, M.; Amann, J.; Carbone, D.; Garassino, M.; Croce, C.; Coppola, V.
- Source
- In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2123-S2124
- Subject
- Language
- ISSN
- 1556-0864